The psychedelics industry received a boost in confidence this week by way of a new market report from banking giant Morgan Stanley. By Bryan Mc

Ellen Meyers has lived with the consuming grief of losing her only child for more than a decade. Ketamine therapy is helping her find some

Psychiatrists express concern about the safety of taking the mind-altering anesthetic at home. By Brianna Abbott and Daniela Hernandez – 10/30/2022 Startups are prescribing ketamine

By CARLA K. JOHNSON – 8/24/2022 The compound in psychedelic mushrooms helped heavy drinkers cut back or quit entirely in the most rigorous test of

Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such

By Sonya Collins Medically Reviewed by Dan Brennan, MD on May 04, 2022 Jeff Winograd didn’t know an adult life without depression. Since he was

By Max Savage Levenson, 9/7/2022 Last night, Sept. 6, the San Francisco Board of Supervisors gave unanimous approval to a resolution that effectively decriminalizes entheogens

The medical benefits of psychedelic drugs have gone from Age of Aquarius punchline to solid science, but the startups racing to market might still be

by Bob Yirka, Medical Xpress – 7/28/2022   A team of researchers at the University of Geneva has found that ketamine is unlikely to be

Psilocybin, the ingredient in magic mushrooms, along with talk therapy, showed significant benefit in the largest clinical trial of its kind. By Kaitlin Sullivan, Akshay

PAST 12-MONTH LSD USE RATE INCREASED FROM 0.9 PERCENT IN 2002 TO 4 PERCENT IN 2019 Hallucinogen use has increased since 2015, overall and particularly

By Black Swan, MD – 7/3/2021 I’m on a plane in a viral pandemic headed for Rythmia, a life advancement center in Costa Rica, to